Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Drazcanna Inc (PK:DZCA)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEC Form 4 filings for DZCA*US within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 22, 2024 09:00 ET
EV Electra Announces Next Steps in Organizational Transformation
Acquisition of Emily GT and PONS Projects from NEVS, Pending Reverse Merger with DrazCanna, Inc. (OTC PK: DZCA), and Organizational Development
Read full article
Dec 01, 2023 09:30 ET
EV Electra Secures Future of Emily and PONS Projects through Acquisition from NEVS
EV Electra Broadens its Horizons: Key Acquisition Drives International Growth in Electric Vehicle Industry Announced at eCarExpo
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.70
--
--
Price to Sales - TTM
0.73
4.20
3.22
Price to Book - most recent quarter
--
2.06
2.10
Price to Cash Flow per share - TTM
--
13.51
13.91
Price to Free Cash Flow per share - TTM
--
25.44
23.90
See all valuations

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing.

See business summary

 

Twitter

Search (past week) for $DZCA

  • No tweets found